Biotech Investissement (www.mabexperts.com) separates from its subsidiary Diaclone by selling it to Medix Biochemica.
The arrival of Diaclone in the Medix group will allow it to access new international markets, and therefore to continue its growth in the In Vitro Diagnostics (IVD) market.
Our group will now focus on the development of biomanufacturing services for plasmid DNAs, antibodies and recombinant proteins with in particular the upcoming construction of a new DNA production unit, GMP grade (BPF) at RD-BIOTECH.

Link to the press release: Biotech Investissement communication
Contact us for more information!

Discover and test our FastELISA Kits: The quickest ELISA Kits on the market!
Easy one-step process – Results in less than 30 minutes – Colored pipetting tracking – Ready-to-use reagents

Applications:
- Ig quantification (Screening of therapeutic antibodies, Production monitoring, Selection of ‘goodproducer’ clones, Pharmacokinetics, Validation of vectors, …)
- Ig isotyping
- Cell contaminant detection
And new kits coming soon!

Contact us for more information!

The entire RD-Biotech team is proud to have participated in the development of BioNTech’s mRNA COVID-19 vaccine and thank them for putting their trust in our company!

To the: BioNTech press release

RD-Biotech is proud to produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip developed by Coris BioConcept!
RD-Biotech, a major French actor in the production of monoclonal antibodies and recombinant proteins, is proud to be a qualified Partner of the Belgian company Coris BioConcept regarding the development of the new IVD rapid test COVID-19 Ag Respi-Strip now manufactured by Coris BioConcept.

Contact us for more information!